IN185384B - - Google Patents

Info

Publication number
IN185384B
IN185384B IN1499DE1996A IN185384B IN 185384 B IN185384 B IN 185384B IN 1499DE1996 A IN1499DE1996 A IN 1499DE1996A IN 185384 B IN185384 B IN 185384B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Hiroki Kodama
Yoshimi Niwano
Kazuo Kanai
Original Assignee
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Nohyaku Co Ltd filed Critical Nihon Nohyaku Co Ltd
Publication of IN185384B publication Critical patent/IN185384B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN1499DE1996 1995-07-08 1996-07-05 IN185384B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19617495 1995-07-08

Publications (1)

Publication Number Publication Date
IN185384B true IN185384B (enExample) 2001-01-13

Family

ID=16353435

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1499DE1996 IN185384B (enExample) 1995-07-08 1996-07-05

Country Status (21)

Country Link
US (1) US5900488A (enExample)
EP (1) EP0839035B1 (enExample)
KR (1) KR100386491B1 (enExample)
CN (1) CN1091596C (enExample)
AT (1) AT407832B (enExample)
CA (1) CA2226214C (enExample)
CH (1) CH692045A5 (enExample)
DE (1) DE19681478B4 (enExample)
DK (1) DK176599B1 (enExample)
ES (1) ES2137888B1 (enExample)
FI (1) FI119357B (enExample)
GB (1) GB2317615B (enExample)
IL (1) IL122618A (enExample)
IN (1) IN185384B (enExample)
LU (1) LU90190B1 (enExample)
NO (1) NO980055L (enExample)
NZ (1) NZ311796A (enExample)
SE (1) SE9800016L (enExample)
TW (1) TW450969B (enExample)
WO (1) WO1997002821A2 (enExample)
ZA (1) ZA965745B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127397A (en) * 1996-12-10 2000-10-03 Nihon Nohyaku Co., Ltd. Optically active (R)-(E)-(4-substituted-phenyl-1,3-dithiolan-2-ylidene)-1-imidazolylaceto nitrile derivative, antifungal composition comprising the same, and method for producing the same
EP1537868B1 (en) * 2002-06-18 2011-08-24 Pola Pharma Inc. Antifungal medicinal compositions
AU2003242235A1 (en) * 2002-06-18 2003-12-31 Pola Chemical Industries Inc. Antifungal medicinal composition
US8058303B2 (en) 2006-03-08 2011-11-15 Nihon Nohyaku Co, Ltd Pharmaceutical composition for external use
MX2008011435A (es) * 2006-03-08 2009-02-03 Nihon Nohyaku Co Ltd Composicion farmaceutica para uso externo.
AU2006339841B2 (en) * 2006-03-08 2012-08-30 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
KR101184834B1 (ko) * 2007-08-27 2012-09-20 니혼노야쿠가부시키가이샤 진균성 피부염용제
JP5529539B2 (ja) 2007-09-05 2014-06-25 株式会社ポーラファルマ 医薬組成物
JP5345937B2 (ja) 2007-09-05 2013-11-20 株式会社ポーラファルマ 抗真菌組成物
JP5453093B2 (ja) 2007-09-05 2014-03-26 株式会社ポーラファルマ 抗真菌医薬組成物
CN102395274B (zh) 2009-02-13 2014-03-12 托派卡医药股份有限公司 抗真菌制剂
EP2416758B8 (en) 2009-04-09 2017-10-18 Pola Pharma Inc. Antimycotic pharmaceutical composition
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
WO2011024620A1 (en) 2009-08-25 2011-03-03 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP5832451B2 (ja) 2010-06-11 2015-12-16 株式会社ポーラファルマ 抗真菌医薬組成物
CN103012385B (zh) * 2012-02-17 2015-07-08 山东威智医药工业有限公司 卢立康唑的晶型及其制备方法
CN104284662A (zh) * 2012-09-14 2015-01-14 宝丽制药股份有限公司 晶体及包含该晶体的药物制剂
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
WO2014041708A1 (en) * 2012-09-14 2014-03-20 Pola Pharma Inc. Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal
US9068958B1 (en) 2012-09-14 2015-06-30 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and pharmaceutical composition prepared by containing the crystal
JP6279583B2 (ja) * 2013-01-28 2018-02-14 株式会社ポーラファルマ アスペルギルス等の病原微生物による疾患用の医薬組成物
CN104968344A (zh) * 2013-01-28 2015-10-07 宝丽制药股份有限公司 针对由病原微生物诸如念珠菌引起的疾病的药物组合物
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5680161B1 (ja) * 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
WO2015162271A1 (en) * 2014-04-25 2015-10-29 Syngenta Participations Ag Microbiocidal imidazole derivatives
EP3230280A4 (en) * 2014-12-12 2018-05-09 Glenmark Pharmaceuticals Limited Process for preparation of luliconazole
WO2017108972A1 (en) 2015-12-21 2017-06-29 Laboratorios Lesvi, S.L. Compounds of r-(-)-(e)-[4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-1 -imidazolylacetonitrile-ha (luliconazole-ha) as antifungals
CN106008166B (zh) * 2016-05-17 2018-09-25 上海福乐医药科技有限公司 一种手性2-氯-1-(2,4-二氯苯基)乙醇的工业化生产方法
US11185548B2 (en) 2016-12-23 2021-11-30 Helmholtz Zentrum Munchen—Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) Inhibitors of cytochrome P450 family 7 subfamily B member 1 (CYP7B1) for use in treating diseases
TR201714882A2 (tr) 2017-10-03 2019-04-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari
US10898470B1 (en) 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient
WO2023131969A1 (en) * 2022-01-09 2023-07-13 Kimia Biosciences Limited Improved process for the preparation of luliconazole

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218736B1 (en) * 1985-10-10 1993-04-07 Nihon Nohyaku Co., Ltd. A ketene s,s-acetal derivative, a process for manufacturing thereof and a method for curing mycosis by administering it
DE3587252T2 (de) * 1985-10-09 1993-07-15 Nihon Nohyaku Co Ltd Keten-s,s,-acetalderivate, verfahren zu ihrer herstellung und methode zur heilung von mykose unter verwendung dieser derivate.
JP3030780B2 (ja) * 1988-12-29 2000-04-10 日本農薬株式会社 光学活性なケテンジチオアセタール誘導体及びその製造方法
JPH0386337A (ja) * 1989-08-28 1991-04-11 Maeda Seisakusho:Kk エクスパンディングチャックを用いた多重巻締め機および多重巻締め方法
CN1038247C (zh) * 1990-05-16 1998-05-06 云南省建筑材料科学研究设计院 一种新型磷石膏胶结料
JP3038519B2 (ja) * 1992-01-28 2000-05-08 日本農薬株式会社 創傷治癒促進剤

Also Published As

Publication number Publication date
WO1997002821A3 (en) 1997-02-20
ATA906196A (de) 2000-11-15
GB2317615B (en) 1998-09-02
NO980055D0 (no) 1998-01-06
ZA965745B (en) 1997-01-27
AU6319296A (en) 1997-02-10
WO1997002821A2 (en) 1997-01-30
EP0839035A2 (en) 1998-05-06
GB9726766D0 (en) 1998-02-18
HK1009751A1 (en) 1999-06-11
IL122618A0 (en) 1998-08-16
AT407832B (de) 2001-06-25
FI980023A0 (fi) 1998-01-07
CA2226214A1 (en) 1997-01-30
EP0839035B1 (en) 2002-10-02
KR19990028772A (ko) 1999-04-15
NO980055L (no) 1998-03-06
KR100386491B1 (ko) 2003-08-21
CN1194582A (zh) 1998-09-30
LU90190B1 (de) 1998-03-02
TW450969B (en) 2001-08-21
CN1091596C (zh) 2002-10-02
DK176599B1 (da) 2008-10-27
ES2137888A1 (es) 1999-12-16
FI119357B (fi) 2008-10-31
IL122618A (en) 2002-07-25
GB2317615A (en) 1998-04-01
US5900488A (en) 1999-05-04
SE9800016D0 (sv) 1998-01-07
ES2137888B1 (es) 2001-01-01
FI980023L (fi) 1998-01-07
NZ311796A (en) 1999-06-29
SE9800016L (sv) 1998-01-07
CA2226214C (en) 2007-04-17
CH692045A5 (de) 2002-01-15
DE19681478T1 (de) 1998-07-02
AU697571B2 (en) 1998-10-08
MX9710401A (es) 1998-07-31
DE19681478B4 (de) 2006-09-21
DK1398A (da) 1998-01-07

Similar Documents

Publication Publication Date Title
BR122012014331A2 (enExample)
BRPI9612258B1 (enExample)
BRPI9612138B1 (enExample)
EP0721236A3 (enExample)
FR2729697B1 (enExample)
FR2729190B1 (enExample)
IN182758B (enExample)
AU1627395A (enExample)
BR7502120U (enExample)
IN183668B (enExample)
IN181889B (enExample)
IN183363B (enExample)
IN185102B (enExample)
IN183327B (enExample)
IN182375B (enExample)
CN3035871S (enExample)
CN3029801S (enExample)
CN3032390S (enExample)
CN3032692S (enExample)
CN3034473S (enExample)
CN3030542S (enExample)
CN3031655S (enExample)
CN3029479S (enExample)
EP0784318A4 (enExample)
CN3035870S (enExample)